Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Using chest compressions first just as successful as immediate defibrillation after cardiac arrest

September 8, 2010 9:34 pm | by EurekAlert | News | Comments

(University of Michigan Health System) In cardiac arrest, is it best to start pumping on the victim's chest or give an immediate shock to the heart? The University of Michigan learns both rescue strategies are effective, yet chest compressions before defibrillation may be best in events...

TOPICS:

Abnormal body weight related to increased mortality in colon cancer patients

September 8, 2010 9:33 pm | by EurekAlert | News | Comments

(American Association for Cancer Research) Postmenopausal women diagnosed with colon cancer may be at increased risk of death if they fail to maintain a healthy body weight before cancer diagnosis, according to a study published in the September issue of Cancer Epidemiology, Biomarkers &...

TOPICS:

ResMed says 2-for-1 stock split is complete

September 8, 2010 1:45 pm | by The Associated Press | News | Comments

Respiratory equipment maker ResMed Inc. confirmed Wednesday it completed a two-for-one stock split on Aug. 30.The split doubled the company's share count to nearly 151.4 million while halving the price of the shares. ResMed stock closed at $31.69 Wednesday, down 36 cents.

Advertisement

Stanford land-use expert brings satellite data down to Earth

September 8, 2010 1:38 pm | by EurekAlert | News | Comments

(Stanford University) By integrating remote satellite imagery with revelations from door-to-door interviews, Stanford University geographer Eric Lambin and his colleagues are exploring the complex conditions that give rise to a broad range of land-use challenges -- from the...

TOPICS:

Manufacturers Take a Step to Reduce Carbon Footprint

September 8, 2010 1:37 pm | by Society of Manufacturing Engineers | News | Comments

DEARBORN, Mich., September 8, 2010 — The demand for sustainability is growing stronger every day, and manufacturers are looking for ways to comply in order to reduce their impact on the environment and increase profitability. More

Patients Should Expect 'Long Life' from their Joint Replacements!

September 8, 2010 1:36 pm | by Bio-Medicine.Org | News | Comments

GLEN COVE, N.Y., Sept. 8 /- In response to the news that DePuy Orthopaedics, the manufacturer of an artificial hip system, issued a recall of its ASR product line after data indicated a higher than expected need for device replacement surgery five years after the initial procedure, Dr....

TOPICS:

Luminex MAGPIX System Shown to be More Cost Effective and Efficient Than Conventional ELISA Method in Initial Study

September 8, 2010 1:36 pm | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Sept. 8 /- Luminex Corporation (Nasdaq: LMNX ), today announced that initial results from a study conducted at the NMI Natural and Medical Sciences Institute at the University of Tubingen in Germany demonstrate that its MAGPIX® system provides more cost effective and...

TOPICS:

Atrium Recognized by Business NH Magazine

September 8, 2010 1:36 pm | by Bio-Medicine.Org | News | Comments

HUDSON, N.H., Sept. 8 /- Atrium Medical Corporation is proud to announce that it has been recognized by Business NH Magazine's September 2010 publication of Top 100 Private Companies in New Hampshire . The company has been ranked #12 of the fastest growing private firms in NH, and #9...

TOPICS:
Advertisement

Stereotaxis Announces First-Ever, Prospective, Comparative Clinical Trial Outcome for VT Patients

September 8, 2010 1:36 pm | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Sept. 8 /- Stereotaxis, Inc. (Nasdaq: STXS ) highlighted significant new additions to the body of evidence demonstrating exceptional clinical outcomes achieved with its Niobe® Magnetic Navigation System in ventricular tachycardia (VT) ablation. At the European Cardiology...

TOPICS:

Masimo to Present at Stifel Nicolaus 2010 Healthcare Conference

September 8, 2010 1:34 pm | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 8 /- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the Stifel Nicolaus 2010 Healthcare Conference at the Four Seasons Hotel in Boston on Wednesday, September 15, at 8:00 a.m. ET.  A live audiocast of the presentation will...

TOPICS:

The Pancreatic Cancer Action Network and AACR to Award Nearly $3 Million in Pancreatic Cancer Research Grants

September 8, 2010 1:34 pm | by AACR | News | Comments

Applications are being accepted for a variety of grants totaling nearly $3 million. PHILADELPHIA — The American Association for Cancer Research in partnership with the Pancreatic Cancer Action Network is now accepting applications for the 2011 research grants program. The program is...

TOPICS:

Medical Devices Technology Innovation Partnership (MD-TIP) Workshop, October 26, 2010

September 8, 2010 1:31 pm | by U.S. Food & Drug Administration | News | Comments

Innovation, Technology Transfer and Scientific Interchange: Leveraging Academic and FDA Collaborations to Resolve Unmet Public Health Needs

TOPICS:

Class I Medical Device Recall: AngioScore Inc. - AngioSculpt EX PTCA Scoring Balloon Catheter

September 8, 2010 1:31 pm | by U.S. Food & Drug Administration | News | Comments

Reason for Recall: The PTCA catheters may become separated during use in which fragments of the catheter may become lodged in coronary arteries. This may result in serious injuries, including death.

TOPICS:

Federal Register: Guidance for Industry and Food and Drug Administration Staff; Class II Special Controls Guidance Document for Certain Percutaneous Transluminal Coronary Angi...

September 8, 2010 1:30 pm | by U.S. Food & Drug Administration | News | Comments

The guidance was developed as a special control to support the reclassification of PTCA catheters, other than cutting/scoring PTCA catheters, from class III (premarket approval) into class II (special controls).

TOPICS:

Federal Register: Cardiovascular Devices; Reclassification of Certain Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheters

September 8, 2010 1:30 pm | by U.S. Food & Drug Administration | News | Comments

The FDA is reclassifying the device type, standard PTCA catheters, from class III (premarket approval) into class II (special controls). Cutting/scoring PTCA catheters remain in class III and continue to require PMAs.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading